How the immune system could stymie some CRISPR gene therapies – Nature.com
Nature.com |
How the immune system could stymie some CRISPR gene therapies
Nature.com Is this the end for CRISPR-Cas9 in gene therapy? Not likely, given the tremendous interest in this approach and the wealth of alternative enzymes to choose from. “Another potential solution is to develop a Cas9 system from bacteria that do not colonize … |
